Interestingly, there was a nonsignificant trend indicating more pronounced benefits among male or younger patients, as well as those with diabetes mellitus, hypertension, chronic kidney disease, hyperlipidemia, and coronary artery disease.
← all excerpts
Artificial intelligence-assisted diagnosis and prognostication in low ejection fraction using electrocardiograms in inpatient department: a pragmatic randomized controlled trial.
1
—
—